Esperion Therapeutics (espr 5.75 06/15/30)
13F holders, Q2 2026 (June 30)1holders
$1.21avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Esperion Therapeutics (espr 5.75 06/15/30) in their 13F filings. The largest holder was Meteora Capital, LLC ($5.6M).
- Company
- Esperion Therapeutics (espr 5.75 06/15/30)
- CUSIP
- 29664WAD7
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5.6M |
| Exits | 0 | $0 |
Ownership 1 holders
| Meteora Capital, LLC | 0.47% | New | 4,590,000 | $5.6M |
"% of holder's portfolio" is ESPERION THERAPEUTICS (ESPR 5.75 06/15/30)'s weight in each manager's 13F, not the share of Esperion Therapeutics (espr 5.75 06/15/30) the manager owns.